Advocacy intelligence hub — real-time data for patient organizations
Columbia University — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Kygevvi
(doxecitine and doxribtimine)Orphan drugUCB, Inc.
12.1 Mechanism of Action Administration of KYGEVVI is intended to incorporate the pyrimidine nucleosides, deoxycytidine and deoxythymidine, into skele...